129 related articles for article (PubMed ID: 32730788)
1. Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity - diabetes?
Pontiroli AE; La Sala L; Chiumello D; Folli F
Diabetes Res Clin Pract; 2020 Sep; 167():108342. PubMed ID: 32730788
[No Abstract] [Full Text] [Related]
2. Diabetes, Obesity, and Risk Prediction of Severe COVID-19.
Muniyappa R; Wilkins KJ
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32663259
[No Abstract] [Full Text] [Related]
3. Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis.
Riddle MC
Diabetes Care; 2020 Oct; 43(10):2336-2338. PubMed ID: 32753458
[No Abstract] [Full Text] [Related]
4. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
Singh AK; Singh R
Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
[TBL] [Abstract][Full Text] [Related]
5. Commentary: COVID-19 and diabetes.
Villabona CV
Diabetes Res Clin Pract; 2020 Apr; 162():108138. PubMed ID: 32272191
[No Abstract] [Full Text] [Related]
6. Response to Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398.
Cai Q; Chen J; Xu L
Diabetes Care; 2020 Oct; 43(10):e162. PubMed ID: 32958625
[No Abstract] [Full Text] [Related]
7. Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398.
He Z; Li J
Diabetes Care; 2020 Oct; 43(10):e160-e161. PubMed ID: 32958624
[No Abstract] [Full Text] [Related]
8. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G
Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852
[No Abstract] [Full Text] [Related]
9. Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (
Chung SM; Ahn JH; Moon JS
Diabetes Metab J; 2020 Aug; 44(4):625-626. PubMed ID: 32856805
[No Abstract] [Full Text] [Related]
10. Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (
Kim SY; Kim KS
Diabetes Metab J; 2020 Aug; 44(4):621-622. PubMed ID: 32856803
[No Abstract] [Full Text] [Related]
11. SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?
Scheen AJ
Diabetes Metab; 2020 Oct; 46(5):343-344. PubMed ID: 32562762
[No Abstract] [Full Text] [Related]
12. Timely glucose monitoring-related potential risk of occupational exposure during the pandemic of COVID-19: A diabetologist's perspective.
Wei X; Zhao W; Wang A; Xu Z
Diabetes Res Clin Pract; 2020 Jul; 165():108196. PubMed ID: 32387330
[No Abstract] [Full Text] [Related]
13. Caring for Pediatric Patients with Diabetes amidst the Coronavirus Disease 2019 Storm.
Ho C; Ng NBH; Lee YS
J Pediatr; 2020 Aug; 223():186-187. PubMed ID: 32387113
[No Abstract] [Full Text] [Related]
14. Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407.
Cariou B; Hadjadj S; Wargny M; Pichelin M; Gourdy P
Diabetes Care; 2020 Oct; 43(10):e163-e164. PubMed ID: 32958626
[No Abstract] [Full Text] [Related]
15. Prioritising action on diabetes during COVID-19.
Erzse A; Fraser H; Levitt N; Hofman K
S Afr Med J; 2020 Jun; 110(8):719-720. PubMed ID: 32880294
[No Abstract] [Full Text] [Related]
16. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
[TBL] [Abstract][Full Text] [Related]
17. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
Pirola CJ; Sookoian S
J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32407757
[No Abstract] [Full Text] [Related]
18. COVID-19 and diabetes: a co-conspiracy?
The Lancet Diabetes Endocrinology
Lancet Diabetes Endocrinol; 2020 Oct; 8(10):801. PubMed ID: 32946812
[No Abstract] [Full Text] [Related]
19. Response to Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407.
Chen Y; Yang D; Yang C; Zheng L; Huang K
Diabetes Care; 2020 Oct; 43(10):e165-e166. PubMed ID: 32958627
[No Abstract] [Full Text] [Related]
20. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
Weis N; Thorsteinsson K; Martinussen C; Madsbad S
Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
